Skip to content

Analysis of clinical characteristics and pathogenesis of segmental vitiligo

Analysis of clinical characteristics and pathogenesis of segmental vitiligo

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035934
Enrollment
Unknown
Registered
2020-08-20
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Segmental vitiligo

Interventions

Segmental vitiligo group and control group:nill

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. One or more localized depigmentation spots appeared in the body of the patient after special examination by a clinical dermatologist, and the leukoplakia showed bright white fluorescence under the Wood light, which was diagnosed as segmental vitiligo; 2. Any age; 3. No systemic glucocorticoids, immunomodulators and other treatments were received within 6 months before enrollment; 4. To sign an informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. No pigmented nevus, pityriasis alba, inflammation, decreased after the pigment spots, mottled disease, idiopathic decreased pigment spots and anemia and other pigmented skin diseases; 2. with severe hypertension, diabetes; 3. with active peptic ulcer disease or infection; 4. fracture, trauma repair and (or) with a clear history of osteoporosis; 5. with severe cardiopulmonary disease, liver and kidney dysfunction, blood coagulopathy and/or tumor; 6. with mental illness; 7. Pregnant and/or lactating women; 8. To participate in other clinical research recently.

Design outcomes

Primary

MeasureTime frame
number of immune cells;Cytokine level;Expression of pathogenesis related proteins;Clinical test index;

Countries

China

Contacts

Public ContactJia CHEN

Shanghai Skin Disease Hospital

chenjia_doc@163.com+86 18017336830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026